Yutopar is used to stabilize pregnancy and prevent premature birth in women who are between 22 and 37 weeks pregnant, and who do not have any complications that prevent the use of uterine tocolytics.
Yutopar is also used to control recurrent uterine contractions in cases of miscarriage.
Yutopar also controls uterine contractions, especially in cases of premature birth, as it is a stimulant of adrenaline receptors and the drug binds to beta 2 adrenergic receptors on the surface of the uterine muscle, which leads to muscle relaxation.